Health
U.S. COVID vaccine hopeful using Gates Foundation cash to prepare for human trial – Devdiscourse
The Swiss company’s gene therapy unit is backing the project with technical assistance and supply. Other COVID-19 vaccines use viral vectors, too, though AstraZeneca…
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.
Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising for their single-dose candidate, targeted for room-temperature storage. “We believe there is real potential,” Vandenberghe…
-
Noosa News18 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News20 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News16 hours agoFranz Ferdinand: Australian Tour 2025
-
General17 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win